Daily Archives: March 2, 2021

The new Moderna/NIH B.1.351-specific vaccine study should add the P.1 variant

By on .

By Daniel R. Lucey MD, MPH, FIDSA Two manuscripts from Brazil, newly posted by accomplished researchers on preprint servers, report that the P.1 variant “associated with rapid transmission in Manaus” (by Faria N.  et al.) and reported in the U.S. and 28 other nations, “may escape from neutralizing antibodies generated in response to polyclonal stimulation […]